Analyst Research

Report Title Price
Provider: Pechala's Reports
$25.00
Provider: Pechala's Reports
$15.00
Provider: Reuters Investment Profile
$20.00
Provider: Thomson Reuters Stock Report
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Genomic Health Inc Issues FY 2013 Guidance In Line With Analysts' Estimates


Wednesday, 6 Feb 2013 04:01pm EST 

Genomic Health Inc announced that for fiscal 2013, it expects total revenue in the range of $258-$266 million and GAAP basic net income (loss) per share between a net loss of ($0.12) and net income of $0.08. According to I/B/E/S Estimates, analysts on an average were expecting the Company to report revenues of $262 million and EPS of $0.04 for fiscal 2013. 

Company Quote

29.72
0.6 +2.06%
29 Aug 2014